Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Verbist

Showing results (51-60 of 588) with videos related to

Pageof 59
Sort By:
Antimicrobial Agents and Chemotherapy|May 1, 1980
GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and EnterobacteriaceaeL Verbist, J Verhaegen
Physical Review Letters|May 13, 1996
Simulating the spreading of a drop in the terraced wetting regimeBekink, Karaborni, Verbist, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1984
Effect of temocillin in combination with other beta-lactam antibioticsL Verbist, J Verhaegen
Acta Clinica Belgica|January 1, 1995
In vitro activity of piperacillin/tazobactam against recent clinical isolates from hospitalized patients in ten Belgian hospitalsL Verbist, P Dhoore
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Differentiation and susceptibility of Citrobacter isolates from patients in a university hospitalSofie Arens, Ludo Verbist
Drugs|January 1, 1995
Comparative in vitro activity of BAY Y 3118 against selected speciesL Verbist, J Verhaegen
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Ceftazidime: comparative in-vitro studyL Verbist, J Verhaegen
Antimicrobial Agents and Chemotherapy|March 1, 1981
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidimeL Verbist, J Verhaegen
Journal of Health Psychology|November 22, 2019
Disordered eating behaviours, body image and social networking in a type 1 diabetes populationIrini L Verbist, Laura Condon
Advances in Experimental Medicine and Biology|August 8, 2024
Cytokine Storm Syndromes Associated with Epstein-Barr VirusKatherine Verbist, Kim E Nichols
Pageof 59

Showing results (51-60 of 588) with videos related to

Sort By:
Pageof 59
Antimicrobial Agents and Chemotherapy|May 1, 1980
GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and EnterobacteriaceaeL Verbist, J Verhaegen
Physical Review Letters|May 13, 1996
Simulating the spreading of a drop in the terraced wetting regimeBekink, Karaborni, Verbist, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1984
Effect of temocillin in combination with other beta-lactam antibioticsL Verbist, J Verhaegen
Acta Clinica Belgica|January 1, 1995
In vitro activity of piperacillin/tazobactam against recent clinical isolates from hospitalized patients in ten Belgian hospitalsL Verbist, P Dhoore
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Differentiation and susceptibility of Citrobacter isolates from patients in a university hospitalSofie Arens, Ludo Verbist
Drugs|January 1, 1995
Comparative in vitro activity of BAY Y 3118 against selected speciesL Verbist, J Verhaegen
The Journal of Antimicrobial Chemotherapy|October 7, 2009
Ceftazidime: comparative in-vitro studyL Verbist, J Verhaegen
Antimicrobial Agents and Chemotherapy|March 1, 1981
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidimeL Verbist, J Verhaegen
Journal of Health Psychology|November 22, 2019
Disordered eating behaviours, body image and social networking in a type 1 diabetes populationIrini L Verbist, Laura Condon
Advances in Experimental Medicine and Biology|August 8, 2024
Cytokine Storm Syndromes Associated with Epstein-Barr VirusKatherine Verbist, Kim E Nichols
Pageof 59